Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 9,270.00
-470.00 (-4.83%)
Aug 21, 2026, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 670.61 billion as of August 21, 2026. Its market cap has increased by 76.75% in one year.
Market Cap
670.61B
Enterprise Value
687.06B
Revenue
53.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,270.00
ChartMarket Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 670.61B, an increase of 611.44%. That is a compound annual growth rate of 8.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 670.61B | 32.28% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaResearch | 4.16T |
| Sam Chun Dang Pharm. | 3.95T |
| ST Pharm | 2.08T |
| Mezzion Pharma | 1.92T |
| Oscotec | 1.40T |
| DongKook Pharmaceutical | 801.62B |
| CG Invites | 61.52B |
| Cellid, | 51.87B |